53-311-0
Tocris Bioscience™ CPI 203
Manufacturer: Tocris Bioscience™
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| Each of 1 | 53-311-0-Each-of-1 | In Stock | ₹ 42,223.86 |
53-311-0 - Each of 1
In Stock
Quantity
1
Base Price: ₹ 42,223.86
GST (18%): ₹ 7,600.295
Total Price: ₹ 49,824.155
Purity
>98%
Product Type
CPI 203
Inhibitors
CPI 203
Quantity
10 mg
Molecular Weight (g/mol)
399.9
Related Products
Description
- CPI 203 is a BET bromodomain inhibitor
- Downregulates Myc expression, causes G1 cell cycle arrest and attenuates cell proliferation in human pancreatic neuroendocrine tumors
- Arrests the growth of T cell acute lymphoblastic leukemia cells in vitro (EC50 = 91.2 nM)
- Also enhances the antitumor effect of rapamycin (Cat
- No
- 1292) in vitro and attenuates rapamycin induced Akt activation
- Also enhances fibroblast reprogramming to hiPSCs at low concentration
- Orally bioavailable.